Idarucizumab (Praxbind) Dabigatran Reversal Dosing

Provides idarucizumab dosing for urgent dabigatran reversal: 5 g IV (2 × 2.5 g vials administered consecutively) for life-threatening bleeding or urgent surgery. Reversal is complete within minutes and sustained for at least 24 hours in most patients (RE-VERSE AD trial).

Use the full interactive calculator below, or

Related Calculators

Frequently Asked Questions